HILL STEPHEN J. (Chief Technical Ops. Officer) sold 0.5% of their position (89.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $1.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/11/2026ACC: 0001866154-26-000004
Officer· Chief Technical Ops. Officer
Since Jun 2021
-89.00
Net shares
Net seller
$1.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
89.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−89.00
Price / share
$14.34
Trade value
$1.28K
% of position
0.5%
8/10/2026
17.89K→17.80K
Total
Net shares
−89.00
Net value
-$1.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | S · Sale | −89.00 | $14.34 | $1.28K | 0.5% | 17.89K | 17.80K |
| Total | −89.00 | -$1.28K | ||||||
Derivative Transactions0
No derivative transactions reported